Coverage of anti-obesity medications under Medicare and Medicaid.
2026 · 3rd Quarter (July 1 - Sep 30)
ZEALAND PHARMA US, INC.
Filed by DLA PIPER LLP (US).
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Oct 7, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- DLA PIPER LLP (US)
- Client
- ZEALAND PHARMA US, INC.
- Filing UUID
- b48d879e-e38e-40a8-9fdb-3a046d77aab2
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.